PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Clin Pathol. 2007 July; 60(7): 835–837.
PMCID: PMC1995799

Sebaceous hyperplasia of the vulva: a clinicopathological case report with a review of the literature

Sebaceous hyperplasia consists of multiple asymptomatic small yellow papules with a central depression, occurring most commonly on the forehead and cheeks, but occasionally affecting the areola,1 chest2 or genital skin.3 The lesions are sometimes mistaken clinically for basal‐cell carcinoma. Sebaceous hyperplasia belongs to the group of epidermal tumours with sebaceous differentiation. Farina et al4 suggested that hyperplasia in the sebaceous gland is analogous with trichofolliculoma. Although termed hyperplasia, they concluded that sebaceous hyperplasia is a benign neoplasm rather than hyperplasia as these lesions do not involute clinically. By contrast, the absence of significant enlargement of sebaceous lobules, and the sharp demarcation of the lesion distinguish it from hypertrophy. Thus, sebaceous hyperplasia is now considered as a hamartoma rather than a true neoplasm.5,6

A universally accepted definition of sebaceous hyperplasia is not yet available. However, Barnhill and Crowson7 defined sebaceous hyperplasia by the presence of [gt-or-equal, slanted]4 sebaceous lobules attached to the infundibulum of each pilosebaceous unit.

Case report

A 31‐year‐old woman presented to the dermatology outpatients clinic with the appearance of two newly pigmented areas on the vulva, within the past 6 months. On examination, the lesions were darkly pigmented polypoidal papule (12 mm in diameter) and macule (5 mm in diameter) on the left labium minus and at the vestibule, respectively. They were non‐tender without obvious textural change, and the surrounding skin was normal. Her gynaecological history was uncomplicated and she had had one normal pregnancy at the age of 20 years. Two biopsy specimens were taken. One was from the left vulva and the other one was from the mid‐line region. Both lesions showed pigmented areas. The clinical diagnoses offered included melanocytic macule and benign tumour.

Methods

Sections were examined under routine light microscope using formalin‐fixed, paraffin‐wax‐embedded tissue stained routinely with H&E. Immunohistochemical examination with a panel of stains, including antibodies to epithelial membrane antigen (1:50 dilution, Dako, Cambridgeshire, UK) and human milk fat globulin 1 (HMFG1; 1:25 dilution, Vector, Peterborough, UK) was performed on the paraffin wax blocks. Appropriate positive controls were run concurrently for all antibodies tested. Mouse non‐immune sera were substituted for negative controls. Tissue submitted for ultrastructural examination was retrieved from the processed paraffin wax block. This involved dewaxing in xylene, hydrating through graded alcohols, osmicating, dehydrating through alcohol and propylene oxide, and infiltrating in TAAB EMIX epoxy resin (TAAB Laboratories, Aldermaston, Berkshire, UK). After polymerisation, sections were cut at 100 nm on a Reichert‐Jung Ultracut E (Leica Microsystems, Buckinghamshire, UK) using a diamond knife; the sections were stained with alcoholic uranyl acetate and Reynold's lead citrate. Examination was on a Phillips 400T transmission electron microscope. Electron micrographs were taken using Kodak EM plate film (Agar Scientific ltd, Stansted, UK).

Results

Microscopic examination of the first lesion showed an origin from sebaceous ducts and glands with a lobulated architecture. The lobules were composed of enlarged sebaceous glands (>4 around each pilosebaceous unit), which appeared to extend down into the dermis. The cells were predominantly mature sebocytes with a peripheral germinative layer, which was not prominent. Cytologically, the cells displayed a foamy, vesiculated cytoplasm and a central nucleolus with no atypical features (fig 1A,B1A,B).). In addition, centrally, the epidermis displayed basal hyperpigmentation and mild lentiginous hyperplasia of basal melanocytes (fig 1C,D1C,D).

figure cp33555.f1
Figure 1 (A) Photomicrograph showing lobules of mature sebaceous glands attached to central hair follicle (original magnification ×70). (B) High‐power view of sebaceous hyperplasia (original magnification ×250). (C) H&E ...

Immunohistochemical studies using monoclonal antibody against epithelial membrane antigen (1:50 dilution, Dako) and HMFG1 (1:25 dilution, Vector) were strongly positive.

Electron microscopic images showing features typical of sebaceous gland—that is, a multilobular gland lined by a simple squamous epithelium up to two cells deep. The squamous epithelial cells contained bundles of cytokeratin filaments, mitochondria, polyribososmes, rough endoplasmic reticulum and desmosome junctions.

The central portion of the gland was composed of cells, the cytoplasm of which was full of lipid droplets. These lipid droplets were relatively monomorphic and typically 4.5 μm in diameter; unfortunately, owing to the previous processing of paraffin wax block, it was impossible to comment on the proportion of saturated to unsaturated lipid. No cholesterol crystals were identified. In the cytoplasm between the lipid droplets, mitochondria, polyribosomes and short segments of rough endoplasmic reticulum were identified. Owing to paraffin processing, it was impossible to comment on smooth endoplasmic reticulum, or peroxisomes. Lysosomes were not prominent. Desmosomes were present between these cells. Nuclear morphology of both squamous and sebaceous cells was typically oval, smooth outlined, with medium‐sized nucleoli, and contained mostly euchromatin. Between the glands, the connective tissue was composed of fibroblasts and fibrous collagen. Thus, confirming the sebaceous origin of these lobules.

The first lesion was diagnosed as benign vulval lentiginosis (genital melanotic macule) together with sebaceous hyperplasia of the vulva.

The second lesion showed mild hyperkeratosis and acanthosis with a central area displaying prominent basal hyperpigmentation. Melanocytic hyperplasia was not prominent and there was no evidence of dysplasia or malignancy, on multiple levels. No sebaceous lobules were present. This lesion was diagnosed as a genital benign melanotic macule. It also served as an internal control, as otherwise it showed the normal histological features of perivulval skin (fig 22).

figure cp33555.f2
Figure 2 H&E‐stained section of perivulval skin in the second biopsy specimen used as an internal control, original magnification ×100.

Discussion and comments

Sebaceous glands are present throughout the skin, except on the palms and soles. Sebaceous glands are well developed a few weeks after birth, probably due to maternal hormones. They almost disappear during early childhood, especially within the first few months. As a direct result of increased androgen output, sebaceous glands enlarge during puberty and then remain constant until middle age, later tending to decrease slowly from around the 60s onwards.8

Sebaceous hyperplasia of the vulva is exceedingly rare, and only three cases have been reported in the literature5,6,9 so far. Table 11 lists the previous three, and includes the present case. The age range was between 19 and 37 (mean 29.7 and median 31) years. However, it is not only the remarkable rarity of this entity in the vulva that deserves mention but also the existence of some important differences that manifest in the lesions at this site when compared with the common facial lesions. The four cases (including our case) seemed to occur at young age (mean age 24.2 years) compared with a mean age of 61.2 years reported in some series of sebaceous hyperplasia of the face.7,10,11 In addition, the gross appearances of these lesions were polypoid in all cases and were remarkably larger (mean size 19.2 mm in maximum dimension) compared with the 2–3 mm usual size of sebaceous hyperplasia elsewhere in the body. Interestingly, all four cases were not diagnosed clinically, indicating the difficulty in recognising these lesions clinically. However, histologically, these lesions are distinct.

Table thumbnail
Table 1 Previous reports and current report of sebaceous hyperplasia of the vulva

The clinical differential diagnoses offered in the four reported cases (including our case) were condyloma acuminate, inflammatory conditions such as furuncles and, most importantly, vulval neoplasms.

By contrast, the microscopically differential diagnoses include ectopic sebaceous glands (Fordyce's granules (FGs) or spots),12 sebaceous adenoma and sebaceoma. It is important to differentiate sebaceous hyperplasia from FGs as the latter are normally present on the whole surface on the labia minora. FGs are viewed as normal anatomical variation presenting on the buccal mucosa, upper and lower labial mucosa, lip and retromolar areas, although they have been rarely reported on other sites.12,13,14,15,16,17 FGs progressively involute after menopause, and they can sometimes be destroyed by inflammatory skin disorders such as lichen sclerosus. FGs are clinically seen as small yellow papules measuring 1–3 mm in diameter without central depression when labia minora are properly stretched; otherwise, they are not clinically visible. Importantly, FGs are, histologically, seen as ectopic sebaceous glands without attached follicles.7,12,13,14,15,16,17

The pathogenesis of sebaceous hyperplasia is not fully understood. Sebaceous glands are holocrine glands that form secretion by total cellular disintegration and seem to be affected by both internal and external factors. For example, ultraviolet radiation possibly represents a cofactor.8 Prolonged ultraviolet radiation exposure has been shown to cause sebaceous hyperplasia in hairless mice.18,19 However, sebaceous hyperplasia also occurs in sun‐protected sites like the vulval mucosa. Human papillomavirus has also been implicated in the development of sebaceous gland carcinoma.20 In addition, mucus‐secreting glands have been demonstrated to be associated with previous surgery and chronic inflammation.20 Finally, de Berker et al21 reported that sebaceous hyperplasia occurred in 16% of immune‐suppressed organ transplant recipients. Fortunately, none of these cofactors seemed to be present in our patient.

It is also noteworthy, that none of the four reported cases (including our case) recurred, and treatment was by simple excision. However, cryotherapy, cauterisation or topical medications have also been mentioned as valid therapeutic options.

In conclusion, we report a unique case of sebaceous hyperplasia of the vulva in association with benign lentiginosis. It is also important to biopsy any unusual‐looking lesions in the vulva to exclude the possibility of intraepithelial neoplasia and malignancy. The presence of only four patients with sebaceous hyperplasia of the vulva to date showed that this entity is very rare.

Footnotes

Competing interests: None declared.

References

1. Belinchon I, Aguilar A, Tardio J. et al Areolar sebaceous hyperplasia: a case report. Cutis 1996. 5863–64.64 [PubMed]
2. Hogan D J. Sebaceous hyperplasia of the chest. Int J Dermatol 1991. 30306
3. Carson H J, Massa M, Reddy V. Sebaceous gland hyperplasia of the penis. J Urol 1996. 1561441
4. Farina M C, Soriano M L, Escalonilla P. et al Unilateral areolar sebaceous hyperplasia in a male. Am J Dermatopathol 1996. 18417–419.419 [PubMed]
5. Ortiz‐Rey J A, Martin‐Jimenez A, Alvarez C. et al Sebaceous gland hyperplasia of the vulva. Obstet Gynecol 2002. 99919–921.921 [PubMed]
6. Rocamora A, Santonja C, Vives R. et al Sebaceous gland hyperplasia of the vulva: a case report. Obstet Gynecol 1986. 68S63–S65.S65
7. Barnhill R L, Crowson A N. Textbook of dermatopathology. 2nd edn. New York: The McGraw‐Hill Companies, 2004
8. Zouboulis C C, Boschnakow A. Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol 2001. 26600–607.607 [PubMed]
9. Bakaris S, Kiran H, Kiran G. Sebaceous gland hyperplasia of the vulva. Aust N Z J Obstet Gynaecol 2004. 4475–76.76 [PubMed]
10. Schonermark M P, Schmidt C, Raulin C. Treatment of sebaceous gland hyperplasia with the pulsed dye laser. Lasers Surg Med 1997. 21313–316.316 [PubMed]
11. Weedon D. Skin pathology. 2nd edn. Edinburgh: Elsevier Science, 2002
12. Daley T D. Intraoral sebaceous hyperplasia. Diagnostic criteria. Oral Surg Oral Med Oral Pathol 1993. 75343–347.347 [PubMed]
13. Celestino D, Di Carlo M, Proia E. et al Clinical study of Fordyce granules. Stomatol Mediterr 1986. 6147–153.153 [PubMed]
14. Dreher A, Grevers G. Fordyce spots. A little regarded finding in the area of lip pigmentation and mouth mucosa. Laryngorhinootologie 1995. 74390–392.392 [PubMed]
15. Monteil R A. Fordyce' spots: disease, heterotopia or adenoma? Histological and ultrastructural study. J Biol Buccale 1981. 9109–128.128 [PubMed]
16. Nordstrom K M, McGinley K J, Lessin S R. et al Neutral lipid composition of Fordyce' granules. Br J Dermatol 1989. 121669–670.670 [PubMed]
17. Wooten J W, Tarsitano J J, Pratt K T. Case reports/diagnosing uncommon Fordyce granules. Dent Surv 1972. 4860
18. Lesnik R H, Kligman L H, Kligman A M. Agents that cause enlargement of sebaceous glands in hairless mice. I. Topical substances. Arch Dermatol Res 1992. 284100–105.105 [PubMed]
19. Lesnik R H, Kligman L H, Kligman A M. Agents that cause enlargement of sebaceous glands in hairless mice. II. Ultraviolet radiation. Arch Dermatol Res 1992. 284106–108.108 [PubMed]
20. Prayson R A, Stoler M H, Hart W R. Vulvar vestibulitis. A histopathologic study of 36 cases, including human papillomavirus in situ hybridization analysis. Am J Surg Pathol 1995. 19154–160.160 [PubMed]
21. de Berker D A, Taylor A E, Quinn A G. et al Sebaceous hyperplasia in organ transplant recipients: shared aspects of hyperplastic and dysplastic processes? J Am Acad Dermatol 1996. 35696–699.699 [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group